Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zimmer Biomet : JMP Securities Adjusts Price Target on Zimmer Biomet Holdings to $195 From $180, Maintains Market Outperform Rating

05/11/2021 | 09:56am EDT


© MT Newswires 2021
All news about ZIMMER BIOMET HOLDINGS, INC.
09/15ZIMMER BIOMET : Announces Key Additions to 'NewCo' Leadership Team, Transaction ..
AQ
09/14ZIMMER BIOMET : Names Finance Chief for Company Spin-Off
MT
09/14ZIMMER BIOMET : Announces Key Additions to "NewCo" Leadership Team; Transaction ..
PR
09/14Zimmer Biomet Holdings, Inc. Announces Executive Changes
CI
09/14Zimmer Biomet Holdings, Inc. Appoints Richard J. Heppenstall as Chief Financi..
CI
09/03ZIMMER BIOMET : Maintains Q3 Cash Dividend at $0.24 a Share, Payable Oct. 29 to ..
MT
09/03ZIMMER BIOMET : To Pay Q3 Dividend
MT
09/03ZIMMER BIOMET : Announces Quarterly Dividend for Third Quarter of 2021
PR
09/03Zimmer Biomet Holdings, Inc. Announces Quarterly Dividend for Third Quarter o..
CI
08/31Zimmer Biomet Holdings, Inc. Announces New Data Supporting Clinical Benefits ..
CI
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 8 102 M - -
Net income 2021 972 M - -
Net Debt 2021 6 406 M - -
P/E ratio 2021 32,0x
Yield 2021 0,65%
Capitalization 30 641 M 30 641 M -
EV / Sales 2021 4,57x
EV / Sales 2022 4,17x
Nbr of Employees 20 000
Free-Float 66,7%
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 31
Last Close Price 146,72 $
Average target price 188,07 $
Spread / Average Target 28,2%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.-4.78%30 641
ABBOTT LABORATORIES15.80%224 776
MEDTRONIC PLC10.72%174 552
BECTON, DICKINSON AND COMPANY4.69%75 229
HOYA CORPORATION30.10%62 323
ALIGN TECHNOLOGY, INC.34.62%56 839